GlassScriptPhysician profile
Arya Khatiwoda
NPI 1609213636
$5,847.99
in general payments reported to CMS, 2019-2025
24 companies · $555 in 2025
The $555 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $12.97 · 2021: $370 · 2022: $732 · 2023: $876 · 2024: $2,194 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,259 · Travel and Lodging: $1,357 · Education: $9.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,258.62 |
| Travel and Lodging | $1,356.74 |
| Education | $9.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,625.74 | 2021-2024 | Axonics |
| Boston Scientific Corporation | $1,005.98 | 2019-2024 | |
| Teleflex LLC | $378.29 | 2021-2023 | Urolift |
| Olympus America INC. | $350.56 | 2022-2025 | Itind System |
| Medtronic, INC. | $241.63 | 2022-2025 | Interstim |
| Calyxo, INC. | $170.10 | 2025 | Cvac Aspiration System |
| Coloplast Corp | $156.40 | 2019-2025 | Porges Coloplast, Speedicath |
| Astellas Pharma US INC | $115.59 | 2019-2022 | |
| Neotract INC. | $112.33 | 2019 | |
| Photocure INC | $100.90 | 2024 | Cysview |
| Heron Therapeutics, INC. | $98.24 | 2023 | Zynrelef |
| Integra Lifesciences Corporation | $67.86 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Olympus Corporation of The Americas | $65.00 | 2023 | Itind System |
| Abbvie INC. | $62.39 | 2022-2023 | |
| Cook Medical LLC | $60.92 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $40.28 | 2022 | |
| Allergan, INC. | $39.99 | 2019 | |
| Medtronic USA, INC. | $37.15 | 2019 | |
| Urogen Pharma, INC. | $24.80 | 2023 | Jelmyto |
| Acera Surgical, INC. | $24.62 | 2025 | Restrata Wound Matrix |
| Antares Pharma, INC. | $22.41 | 2022 | |
| Laborie Medical Technologies Corp. | $19.16 | 2022 | |
| Solventum Corporation | $18.27 | 2025 | Activ.A.C. |
| Travere Therapeutics, INC. | $9.38 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arya Khatiwoda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.